Adjuvant PD-1 and PD-L1 Inhibitors and Relapse-Free Survival in Cancer Patients: The MOUSEION-04 Study

Adjuvant PD-1 and PD-L1 Inhibitors and Relapse-Free Survival in Cancer Patients: The MOUSEION-04 Study

Background: Adjuvant treatment has always been a cornerstone in the therapeutic approach of many cancers, considering its role in reducing the risk of relapse and, in some cases, increasing overall survival. Adjuvant immune checkpoint inhibitors have been tested in different malignancies. Methods: W...

Full description

Bibliographic Details
Main Authors: Alessandro Rizzo, Veronica Mollica, Andrea Marchetti, Giacomo Nuvola, Matteo Rosellini, Elisa Tassinari, Javier Molina-Cerrillo, Zin W. Myint, Tomas Buchler, Fernando Sabino Marques Monteiro, Enrique Grande, Matteo Santoni, Francesco Massari
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Cancers
Subjects:
adjuvant
immunotherapy
immune checkpoint inhibitors
PD-1
relapse-free survival
Online Access:https://www.mdpi.com/2072-6694/14/17/4142

Internet

https://www.mdpi.com/2072-6694/14/17/4142

Similar Items